CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,763,566
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,763,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Thermopylae Holdings Ltd. 10% owner | Purchase | +60,565 | $11.54 | $699K | 56,194,662 |
| 2026-08-24 | Hayden Michael R Director | Purchase | +53,613 | $10.64 | $570K | 1,373,397 |
| 2026-08-18 | Montalbano John S. Director | Purchase | +10,000 | $11.03 | $110K | 251,000 |
| 2026-08-14 | Booth Andrew Chief Financial Officer | Purchase | +37,200 | $10.32 | $384K | 482,800 |
| 2026-08-12 | Hayden Michael R Director | Purchase | +46,387 | $10.37 | $481K | 1,319,784 |
| 2026-08-11 | Hayden Michael R Director | Gift | −50,000 | 1,273,397 | ||
| 2026-07-01 | Seely Lynn Director | Grant or award · Share option (right to buy) | +152,207 | 152,207 | ||
| 2026-07-01 | Sandor Victor Director | Grant or award · Share option (right to buy) | +152,207 | 152,207 | ||
| 2026-06-11 | Montalbano John S. Director | Grant or award · Share option (right to buy) | +111,701 | 1,141,544 | ||
| 2026-06-11 | Quake Stephen Director | Grant or award · Share option (right to buy) | +111,701 | 306,633 | ||
| 2026-06-11 | Hayden Michael R Director | Grant or award · Share option (right to buy) | +111,701 | 1,011,544 | ||
| 2026-06-03 | Booth Andrew Chief Financial Officer | Option exercise | +250,000 | $0.19 | $48K | 445,600 |
| 2026-06-03 | Booth Andrew Chief Financial Officer | Option exercise · Share option (right to buy) | −250,000 | 8,501,849 | ||
| 2026-05-14 | Montalbano John S. Director | Purchase | +20,000 | $4.77 | $95K | 241,000 |
| 2026-02-27 | Thermopylae Holdings Ltd. 10% owner | Purchase | +38,000 | $3.44 | $131K | 56,134,097 |
| 2026-02-27 | Booth Andrew Chief Financial Officer | Purchase | +42,600 | $3.42 | $146K | 195,600 |
| 2026-02-26 | Thermopylae Holdings Ltd. 10% owner | Purchase | +177,457 | $3.27 | $580K | 56,096,097 |
| 2026-01-01 | Stimart Tryn Chief Legal Officer | Grant or award · Share option (right to buy) | +539,265 | 4,646,012 | ||
| 2026-01-01 | Lecault Veronique Chief Technology Officer | Grant or award · Share option (right to buy) | +539,265 | 5,201,069 | ||
| 2026-01-01 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share option (right to buy) | +2,106,505 | 13,096,837 |
Page 1 of 11 · 203 trades